LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Nasehi, Nahal"
  2. AU="Arun Seth"
  3. AU="Woitok, Mira"
  4. AU="Amparo MoraguesauthorDpto. Ingeniera Civil: Construccin, E.T.S.I. de Caminos, Canales y Puertos, Universidad Politcnica de Madrid, C/ Profesor Aranguren 3, 28040 Madrid, Spain"
  5. AU="Guidry, Jessie"
  6. AU=Mitry Maria A.
  7. AU="Rhodes, Rosamond"
  8. AU="Gromova, Alexandra S"
  9. AU=Ockene Ira
  10. AU=Hirsch Daniela
  11. AU=Navaratnam Annalan MD
  12. AU="Johnson, Matthew Thomas"
  13. AU=Wagstaff Peter GK
  14. AU="Almahboub, Sarah A"
  15. AU="Tuana Aksu"
  16. AU="Bozin, Tonci"
  17. AU="Rachel Marie Towle"
  18. AU="Soriano-Ursúa, Marvin A"
  19. AU="Cagnin, A"
  20. AU="Ivens, Al C"
  21. AU="Juan Mucci"
  22. AU="Alejandro Hlavnika"
  23. AU="Makarenko V."

Suchergebnis

Treffer 1 - 3 von insgesamt 3

Suchoptionen

  1. Artikel: Factors causing timely referral for fetal echocardiography in the final diagnosis of congenital heart malformations: A cross-sectional study.

    Barati, Mojgan / Nasehi, Nahal / Aberoumand, Sareh / Najafian, Mahin / Emami Moghadam, Abdolrahman

    International journal of reproductive biomedicine

    2022  Band 20, Heft 6, Seite(n) 477–482

    Abstract: Background: Congenital heart disease (CHD) is one of the most frequently inherited illnesses associated with adverse outcomes.: Objective: This study aimed to determine the referral cause for fetal echocardiography in the final diagnosis of major CHD. ...

    Abstract Background: Congenital heart disease (CHD) is one of the most frequently inherited illnesses associated with adverse outcomes.
    Objective: This study aimed to determine the referral cause for fetal echocardiography in the final diagnosis of major CHD.
    Materials and methods: In this cross-sectional study, the data of 1772 pregnant women, referred to a diagnostic clinic during 2017-2020, were reviewed. Data were collected from participants on maternal age, gestational age, history of previous child's heart disease, body mass, the order of birth of children (baby birth rank), type of woman's disease, history of poor midwifery, and nuchal translucency (NT).
    Results: Of the 1772 pregnant women, only 33 women (1.8%) had a fetus with CHD major. Abnormality in ultrasound (57.6%), history of abortion (36.4%), increased NT and gestational diabetes (18.2%) and gestational diabetes (18.2%) were identified as the most common referral reasons for fetal echocardiography in these women. Other reasons included a previous child with Down syndrome (12.1%), a previous child with heart disease (12.1%), a history of stillbirth (12.1%), hypothyroidism (12.1%), taking medication during the pregnancy period (9.0%), no underlying disease (9.0%), multiple pregnancies (6.0%), diagnosis with high-risk fetal heart disease (3.0%), high-risk combined aneuploidy screening test in the first trimester (3.0%), in vitro fertilizationpregnancy (3.0%), and having a child with an intellectual disability (3.0%).
    Conclusion: According to the results, it can be concluded that ultrasound abnormality, abortion, increased NT and gestational diabetes are the most important factors for referring pregnant women for fetal echocardiography.
    Sprache Englisch
    Erscheinungsdatum 2022-07-06
    Erscheinungsland Iran
    Dokumenttyp Journal Article
    ZDB-ID 2898387-7
    ISSN 2476-3772 ; 2476-4108
    ISSN (online) 2476-3772
    ISSN 2476-4108
    DOI 10.18502/ijrm.v20i6.11443
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Association between oral contraceptives with lipid profile: results from Hoveyzeh cohort study (HCS).

    Hashemi, Seyed Jalal / Khezri, Rozhan / Saki, Nader / Nasehi, Nahal / Hosseini, Seyed Ahmad / Harizi, Mahmood / Rahimi, Zahra

    BMC women's health

    2023  Band 23, Heft 1, Seite(n) 552

    Abstract: Background: Oral contraceptives (OCs) affect lipid metabolism, which can cause hyperlipidemia, a risk factor for cardiovascular diseases. The study was designed to evaluate the possible changes in lipid profile due to using OCs.: Methods: A cross- ... ...

    Abstract Background: Oral contraceptives (OCs) affect lipid metabolism, which can cause hyperlipidemia, a risk factor for cardiovascular diseases. The study was designed to evaluate the possible changes in lipid profile due to using OCs.
    Methods: A cross-sectional study was conducted from April 2016 to August 2018 among women from the baseline phase Hoveyzeh cohort study (HCS). Sociodemographic data, anthropometric measurements, physical activity, and biochemical blood tests were measured for every participant. Multiple logistic regression was used to adjust the potential confounders.
    Results: Among 2272 participants, 1549 women were OC users, and 723 women were non-user OCs. The mean lipid profile levels were higher in OC users than in non-user OCs. Odds of abnormal Total cholesterol (TC) in OC users were significantly higher than those of non-users OCs [OR = 1.29 (95% CI;1.05 to 1.58)]. Also, the Odds of abnormal low-density lipoprotein (LDL) in OC users was 12% higher than in non-user OCs. However, no significant relationship between abnormal LDL with Oral Contraceptive Pills (OCPs) was observed.
    Conclusions: The mean lipid profile was higher in OC users compared to non-user OCs. This finding highlights the need for public health strategies to prevent and detect hyperlipidemia in user OCs.
    Mesh-Begriff(e) Humans ; Female ; Contraceptives, Oral ; Cohort Studies ; Cross-Sectional Studies ; Lipoproteins, LDL ; Hyperlipidemias/epidemiology
    Chemische Substanzen Contraceptives, Oral ; Lipoproteins, LDL
    Sprache Englisch
    Erscheinungsdatum 2023-10-24
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2050444-5
    ISSN 1472-6874 ; 1472-6874
    ISSN (online) 1472-6874
    ISSN 1472-6874
    DOI 10.1186/s12905-023-02703-7
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Association between Age at Menarche and Metabolic Syndrome in Southwest Iran: A Population-Based Case-Control Study.

    Rahimi, Zahra / Saki, Nader / Cheraghian, Bahman / Sarvandian, Sara / Hashemi, Seyed Jalal / Kaabi, Jamileh / Saki Malehi, Amal / Shahriari, Arman / Nasehi, Nahal

    Journal of research in health sciences

    2022  Band 22, Heft 3, Seite(n) e00558

    Abstract: Background: Age at menarche affects women's health outcomes and could be a risk factor for some diseases, such as metabolic syndrome (MetS). We assessed the association between age at menarche and MetS components in women aged 35-70 in Hoveyzeh, ... ...

    Abstract Background: Age at menarche affects women's health outcomes and could be a risk factor for some diseases, such as metabolic syndrome (MetS). We assessed the association between age at menarche and MetS components in women aged 35-70 in Hoveyzeh, southwest Iran.
    Study design: A case-control study.
    Methods: This case-control study was conducted on 5830 women aged 35-70 years in the Hoveyzeh cohort study (HCS), a part of the PERSIAN cohort study, from 2016-2018. The case group included women with MetS, while the controls were women without MetS. The MetS is determined based on standard NCEP-ATP III criteria. Data from demographic, socioeconomic, and reproductive history were gathered face-to-face through trained interviews. Moreover, laboratory, anthropometrics, and blood pressure measurements were assayed for participants. Multiple logistic regression was used to estimate the association between age at menarche and MetS, with adjustment for potential confounding variables.
    Results: The mean age at menarche was 12.60 ± 1.76 years old. Urban and rural women differed in age at menarche (12.58 ± 1.71 and 12.63 ± 1.83 years, respectively). The study revealed a statistically significant relationship between MetS and menarche age. The odds of developing MetS were 14% higher in women with menstrual age ≤ 11 years than in other groups.
    Conclusion: As evidenced by the results of this study, the odds of having MetS were higher in women whose menarche age was ≤ 11 years. Furthermore, the association between MetS components and age groups at menarche was statistically significant.
    Mesh-Begriff(e) Female ; Humans ; Child ; Adolescent ; Male ; Metabolic Syndrome/epidemiology ; Metabolic Syndrome/etiology ; Cohort Studies ; Case-Control Studies ; Menarche ; Risk Factors ; Iran/epidemiology
    Sprache Englisch
    Erscheinungsdatum 2022-10-19
    Erscheinungsland Iran
    Dokumenttyp Journal Article
    ZDB-ID 2575001-X
    ISSN 2228-7809 ; 2228-7809
    ISSN (online) 2228-7809
    ISSN 2228-7809
    DOI 10.34172/jrhs.2022.93
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang